In this study, we examined the fecal bile acid composition of patients with biopsy-confirmed NAFL and NASH, in conjunction with markers of bile acid synthesis and intestinal farnesoid X receptor (FXR) activation, and compared it against HC. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.